Nuggie’s Maine

12/31/2025

💡

12/31/2025

NEWS
You Might Have Missed

12/30/2025

We bring the wow 🔥

Nothing for sale or trade. For display, entertainment and educational purposes only. Must be 21 and over and have a valid medical card.

12/27/2025

Get to right meow 😁
Nothing for sale or trade. For display, entertainment and educational purposes only. Must be 21 and over and have a valid medical card.

12/24/2025

🔥

Nothing for sale or trade, for display, education and entertainment purposes only. Must be 21+ and have a valid medical card.

12/21/2025

A recent Brazilian clinical trial, published in the Journal of Alzheimer’s Disease and widely reported in December 2025, marks a groundbreaking development in exploring cannabis for Alzheimer’s treatment.

Researchers at the Federal University of Latin American Integration conducted a phase 2, randomized, double-blind, placebo-controlled study involving elderly patients aged 60-80 with mild Alzheimer’s disease.

Building on prior animal studies showing low-dose THC restoring cognition in aged mice and a 2022 case report where microdosing improved symptoms in one patient over 22 months, this trial tested daily oral microdoses of a balanced cannabis extract containing approximately 0.3 mg THC and 0.3 mg CBD—far below psychoactive levels.

Over 24-26 weeks, the treatment group showed stabilized cognitive function, as measured by the Mini-Mental State Examination (MMSE), while the placebo group experienced typical decline.

This pausing of progression represents the first human trial evidence of microdosing cannabinoids potentially halting Alzheimer’s-related cognitive deterioration without significant side effects.

Described as unprecedented, the approach leverages the endocannabinoid system’s role in neuroprotection, which naturally diminishes with age. Though promising, the study’s small sample size and limited scope to certain cognitive metrics highlight the need for larger, longer trials to confirm efficacy and safety.

Current Alzheimer’s therapies offer minimal benefit and often severe side effects, making this low-risk cannabinoid option a hopeful avenue amid rising dementia cases globally.

12/17/2025

NEWS You Might Have Missed






Nothing for sale or trade, for display, educational and entertainment purposes only. Must be 21 and over and have a valid medical card.

12/11/2025

Our glass kicks azz🔥
Nothing for sale or trade. For display, entertainment and educational purposes only. Must be 21 and over and have a valid medical card.

12/10/2025

NEWS you Might Have Missed 🚨

12/08/2025

Pass that glass.
Nothing for sale or trade, for display and entertainment purposes only.

12/08/2025

🔥

In this FOX 7 Care Force, we're looking at the issue of h**p-derived products that many veterans use for relief from post-traumatic stress. First, the state legislature tried to ban them. The governor vetoed that. But now the federal government has banned most of these products. So where does that l...

12/07/2025

Tis the season 🔥
Nothing for sale or trade. For display, entertainment and educational purposes only. Must be 21 and over and have a valid medical card.